Mohsen Nabi‐Afjadi

Author

Mohsen Nabi‐Afjadi

Tarbiat Modares University ORCID

Also Known As

Mohsen Nabi Afjadi, Mohsen Nabi Afjadi, Mohsen Nabi-Afjadi, Mohsen Nabi‐Afjadi

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Tarbiat Modares University Tehran University of Medical Sciences Shahid Beheshti University of Medical Sciences Tabriz University of Medical Sciences Mazandaran University of Medical Sciences

About

Mohsen Nabi‐Afjadi is an author at Tarbiat Modares University specializing in medicine, immunology, and nanomedicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	229
2	Engineering	1	1	18
3	Health Sciences	1	1	38
4	Biomedical Engineering	1	1	18
5	Cell Biology	1	1	38

Mohsen Nabi‐Afjadi

Publications

563

Citations

H-Index

Page 1

	Year	Citations
Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine Maryam Esmaily, Ali Masjedi, Shahin Hallaj, Journal of Controlled Release VaccinationTumor ImmunologyCancer ImmunosurveillanceImmunologyTumor Immunity	2020	91
RETRACTED: Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression Navneet Joshi, Farnaz Hajizadeh, Ehsan Ansari Dezfouli, Life Sciences	2021	54
RETRACTED: Inhibition of HIF-1α/EP4 axis by hyaluronate-trimethyl chitosan-SPION nanoparticles markedly suppresses the growth and development of cancer cells Vahid Karpisheh, Javad Fakkari Afjadi, Mohsen Nabi‐Afjadi, International Journal of Biological Macromolecules	2020	52
Concomitant blockade of A2AR and CTLA‐4 by siRNA‐loaded polyethylene glycol‐chitosan‐alginate nanoparticles synergistically enhances antitumor T‐cell responses Mitra Ghasemi‐Chaleshtari, Seyed Hossein Kiaie, Mahzad Irandoust, Journal of Cellular Physiology	2020	48
Silencing adenosine A2a receptor enhances dendritic cell-based cancer immunotherapy Ali Masjedi, Armin Ahmadi, Sepideh Ghani, Nanomedicine Nanotechnology Biology and Medicine Tumor ImmunologyCancer ImmunosurveillanceImmunologyImmune Checkpoint InhibitorImmunotherapy	2020	48
Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies Behnam Najafiyan, Zahra Bokaii Hosseini, Samar Esmaelian, Biomedicine & Pharmacotherapy Rv NanoparticlesNanotherapeuticsChemoprevention StrategyOxidative StressNanomedicine	2024	38
Different T cell related immunological profiles in COVID-19 patients compared to healthy controls Armin Mahmoud Salehi Khesht, Vahid Karpisheh, Balsam Qubais Saeed, International Immunopharmacology Adaptive Immune SystemT-regulatory CellImmunologyT Cell ImmunityHealthy Controls	2021	34
Macrophage’s role in solid tumors: two edges of a sword Arian Jahandideh, Mahsa Yarizadeh, Maryam Noei-Khesht Masjedi, Cancer Cell International	2023	31
Investigation of insulin-like growth factors/insulin-like growth factor binding proteins regulation in metabolic syndrome patients Somayeh Pouriamehr, Haleh Barmaki, Mozhdeh Rastegary, BMC Research Notes	2019	30
Fighting against amyotrophic lateral sclerosis (ALS) with flavonoids: a computational approach to inhibit superoxide dismutase (SOD1) mutant aggregation Seyed Mostafa Noorbakhsh Varnosfaderani, Melika Sadat Haeri, Ali Sam Arian, Journal of Biomolecular Structure and Dynamics	2023	26

Page 1